You are here

AusPAR: Rivaroxaban

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

30 October 2019
AusPAR Details
AusPAR
Active Ingredient
Rivaroxaban
Product Name
Xarelto
Sponsor
Bayer Australia Ltd
Submission Number
PM-2017-04819-1-3
Submission Type
Extension of indications new dosage
Decision
Approved
AusPAR Date
22 October 2019
Publication Date

30 October 2019